Regen BioPharma issues $125,000 in 10% unsecured debt
RGBP•Regen BioPharma issued Coventry Enterprises a $125,000 unsecured promissory note with a 10% rate and an 18-month term. The note includes $12,500 in guaranteed interest and may convert to common shares at a discount after a default.
1. Note terms
Regen BioPharma issued Coventry Enterprises the $125,000 note on October 27, 2026. Coventry retained $12,500 as an original issue discount, and proceeds repaid $71,557 of existing convertible debt and accrued interest. Principal and $12,500 of guaranteed interest are payable in eight monthly installments of $17,187.50, beginning six months after funding. Upon default, Coventry may convert the note into common shares at 90% of the lowest trading price over the preceding 20 trading days.
